However, NPC patients with elevated levels of BLLF3-IgA and BDLF1-IgA titers had significantly worse DFS, suggesting these two seromarkers may be potential prognostic indicators of NPC (Fig. 6). The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.